![Jun Yi Dai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jun Yi Dai
Directeur Général chez
INDAPTUS THERAPEUTICS, INC.
Fortune : 34 M $ au 30/06/2026
Profil
Jun Yi Dai is currently Chairman & Chief Executive Officer at Indaptus Therapeutics, Inc. starting in 2026, Independent Director at Mega Matrix Corp.
since 2024, and Managing Director at FLMD Pty Ltd. since 2015.
Former roles include Independent Director at Mega Matrix, Inc. Education includes an undergraduate degree from The University of New South Wales.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/06/2026 | 11 250 000 ( 9,93% ) | 34 M $ | 30/06/2026 |
Postes actifs de Jun Yi Dai
| Sociétés | Poste | Début |
|---|---|---|
| INDAPTUS THERAPEUTICS, INC. | Directeur Général | 23/03/2026 |
Mega Matrix Corp.
 Mega Matrix Corp. MiscellaneousMiscellaneous Functions as an investment holding company | Directeur/Membre du Conseil | 10/05/2024 |
Anciens postes connus de Jun Yi Dai
| Sociétés | Poste | Fin |
|---|
Formation de Jun Yi Dai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Mega Matrix Corp.
Mega Matrix Corp. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indaptus Therapeutics, Inc.
 Indaptus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
